MS News & Perspectives

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how stem cell transplant is superior to Gilenya and Tysabri at preventing relapses and easing disability in RRMS patients.

He also reads another report on how early use of DMTs may lead to lower levels of disability but does not appear to slow disability progression over time.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news report on ATA188, a treatment targeting the Epstein-Barr virus which could be integral in treating progressive MS.
He also reads a news article reporting on how ublituximab works better than Aubagio at easing disability in patients with relapsing MS.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting on how exposure to high-efficacy DMTs is linked to an increased risk of cervical abnormalities in women with MS.
He also reads another news article on Tecfidera reducing the risk of experiencing the first MS symptoms in adults with radiologically isolated syndrome.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how genetic variants in genes mostly active in the central nervous system are linked to MS severity.
He also reads a report on how the investigational immunotherapy ATA188 continues to ease disability and prevent brain tissue shrinkage in people with progressive forms of multiple sclerosis.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a study that shows how new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression.
He also reads “MS News That Caught My Eye Last Week: ECTRIMS, Ocrevus, Kesimpta, Epstein-Barr, DMTs” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how a prior Epstein-Barr virus infection may precede the emergence of a biomarker of nerve damage in presymptomatic MS patients.
He also reads a second article about a study focusing on tap speed on a smartphone keyboard and how it is linked to greater disability and worse function in people with MS. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit: https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how fertility treatments do not appear to significantly increase the risk of relapse in women with multiple sclerosis.
He also reads a news article on how treatment with Ocrevus before or during pregnancy does not seem to increase the risk of major pregnancy or infant complications.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study showing that when MS patients stop their disease-modifying treatment, the risk of relapses and disease activity on MRI scans is higher among patients who have RRMS.
He also reads an article on how Ocrevus safely and effectively reduced disease activity in people with early-stage relapsing-remitting multiple sclerosis.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting that the levels of two biomarkers were higher in people with relapsing and progressive MS and most likely to predict how relapsing MS will progress.


He also reads “As Ever, I Prevaricate Before Taking On My Focus: Long COVID-19” by John Connor, from his column “Fall Down Get Up Again”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how the Mediterranean diet is linked to a lower risk of disability outcomes and symptoms in people with MS.

He also reads “New Gadolinium-based Contrast Agent Elucirem Will Soon Be Available for MRIs” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/